Centre de Ressources

Cette section contient des recherches internationales et peut faire référence à des indications qui ne sont pas approuvées dans toutes les régions. Veuillez consulter les indications approuvées localement avant utilisation.

Filtrer par:

Rechercher
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
Innovation happens when clinicians and technology come together.
Stop by the GE HealthCare booth to experience Pulsenmore
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the

Actualités

Nous vous invitons à vous tenir au courant des dernières nouvelles en vous inscrivant à notre newsletter trimestrielle

FAQ

Foire aux questions